Purpose or Objective: Thalamic tumours represent 5.2% of all intracranial tumours and are typically diagnosed in the paediatric population. These tumors arise from glial cells with an aggressive behavior and a high grade histology. They have a poor prognosis. The aim of this study was to find new approaches for defining the clinical target volume for these tumors.
Material and Methods:
Clinical data were collected form archived files of 30 patients diagnosed with thalamic gliomas based on pathologic and radiologic criteria.
Results: Three patterns of tumor spread were found. The first pattern followed the thalamic tributaries of the posterior part of the internal cerebral veins. These were the anterior and superior thalamic veins. For the second pattern the close proximity of the internal cerebral vein branches of the superior thalamic veins was a potential route of spread between the medial surfaces of the thalami. In addition to spread across the midline tumours could also spread along the adjacent tectal, pineal and/or vermian veins. The third pattern of thalamic tumor spread was found in gliomas which use the anterior tributaries of the internal cerebral venous architecture of the posterior and inferior branches from the basal vein of Rosenthal. Purpose or Objective; Evidence for the use of stereotactic radiosurgery (SRS) to 1-3 brain metastases (BM) can be derived from historic prospective trials. With improvements in the ability to control systemic disease, better access to SRS and concerns with WBRT associated neurocognitive toxicity many institutions now offer SRS to patients with greater than 3 metastases. The purpose of this study was to review local control and survival outcomes of patients with 4 or more BM treated with SRS.
Conclusion

Material and Methods:
Patients with BM treated with SRS for 4 or more lesions between June 2011 and April 2015 were identified from a prospective database. Patients were deemed suitable for SRS if they had preserved Karnofsky performance status (> 70), controllable systemic disease and an estimated prognosis of > 6 months with a total intracranial metastatic volume of < 20 cm3. Local control and overall survival rates were estimated using Kaplan Meier curves.
Results: A total of 16 patients (median age 54 years) with 85 lesions were treated with primary pathology as follows: breast 3 (18.6%); lung 5 (31.3%); melanoma 6 (31.3%) and others 2 (12.5%). Median number of lesions treated was 5, with median total volume of BM per patient of 1.63cm3. Minimum follow up post SRS in all patients was 6 months. Six (37.5%) patients had received previous WBRT. Eight patients (50%) experienced distant intracranial relapse, 6 (75%) of whom had not received prior WBRT. Of these 6 patients; 3 (50%) received salvage WBRT, 2 (33.3%) were suitable for further SRS and 1 (16.7%) refused further intervention. Of the 10 patients who had not received WBRT prior to SRS, 6 had confirmed distant relapse. The median whole brain radiotherapy free survival (i.e. time from initial SRS to either salvage WBRT or death) was 6.1 months. Eleven lesions (12.9%) recurred locally after a median of 226 days (range 85 -235) post SRS. Median overall survival was 8.3 months (range 21 -548).
